{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:14:53Z","timestamp":1788326093186,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00403-015-1568-9","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T15:54:47Z","timestamp":1433519687000},"page":"757-766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluating clinical trial design: systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne"],"prefix":"10.1007","volume":"307","author":[{"given":"Sonia A.","family":"Lamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja K.","family":"Sivamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Rahvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00403-014-1482-6","volume":"306","author":"RG Albuquerque","year":"2014","unstructured":"Albuquerque RG, Rocha MA, Bagatin E, Tufik S, Andersen ML (2014) Could adult female acne be associated with modern life? Arch Dermatol Res 306:683\u2013688","journal-title":"Arch Dermatol Res"},{"key":"1568_CR2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.1955.02960340022006","volume":"159","author":"HK Beecher","year":"1955","unstructured":"Beecher HK (1955) The powerful placebo. J Am Med Assoc 159:1602\u20131606","journal-title":"J Am Med Assoc"},{"key":"1568_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/clpt.2011.206","volume":"90","author":"F Benedetti","year":"2011","unstructured":"Benedetti F, Carlino E, Pollo A (2011) Hidden administration of drugs. Clin Pharmacol Ther 90:651\u2013661","journal-title":"Clin Pharmacol Ther"},{"key":"1568_CR4","first-page":"189","volume":"74","author":"WF Bergfeld","year":"2004","unstructured":"Bergfeld WF (2004) The pathophysiology of acne vulgaris in children and adolescents, part 2: tailoring treatment. Cutis 74:189\u2013192","journal-title":"Cutis"},{"key":"1568_CR5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00403-014-1477-3","volume":"306","author":"A Borovaya","year":"2014","unstructured":"Borovaya A, Dombrowski Y, Zwicker S, Olisova O, Ruzicka T, Wolf R, Schauber J, Sardy M (2014) Isotretinoin therapy changes the expression of antimicrobial peptides in acne vulgaris. Arch Dermatol Res 306:689\u2013700","journal-title":"Arch Dermatol Res"},{"key":"1568_CR6","first-page":"705","volume":"5","author":"CG Burkhart","year":"2006","unstructured":"Burkhart CG (2006) A chemical look at benzoyl peroxide may prove helpful. J Drugs Dermatol 5:705","journal-title":"J Drugs Dermatol"},{"key":"1568_CR7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0190-9622(83)70211-2","volume":"9","author":"DK Chalker","year":"1983","unstructured":"Chalker DK, Shalita A, Smith JG Jr, Swann RW (1983) A double-blind study of the effectiveness of a 3\u00a0% erythromycin and 5\u00a0% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 9:933\u2013936","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5414\/CP201694","volume":"50","author":"WL Chiou","year":"2012","unstructured":"Chiou WL (2012) Low intrinsic drug activity and dominant vehicle (placebo) effect in the topical treatment of acne vulgaris. Int J Clin Pharmacol Ther 50:434\u2013437","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1568_CR9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1098\/rstb.2010.0398","volume":"366","author":"L Colloca","year":"2011","unstructured":"Colloca L, Miller FG (2011) How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci 366:1859\u20131869","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1568_CR10","first-page":"160","volume":"5","author":"JQ Rosso Del","year":"2006","unstructured":"Del Rosso JQ, Tanghetti E (2006) The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5\u00a0%\/clindamycin 1\u00a0% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. J Drugs Dermatol 5:160\u2013164","journal-title":"J Drugs Dermatol"},{"key":"1568_CR11","first-page":"281","volume":"82","author":"ZD Draelos","year":"2008","unstructured":"Draelos ZD, Callender V, Young C, Dhawan SS (2008) The effect of vehicle formulation on acne medication tolerability. Cutis 82:281\u2013284","journal-title":"Cutis"},{"key":"1568_CR12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000017869","volume":"196","author":"EA Eady","year":"1998","unstructured":"Eady EA (1998) Bacterial resistance in acne. Dermatol 196:59\u201366","journal-title":"Dermatol"},{"key":"1568_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1994.tb08519.x","volume":"131","author":"EA Eady","year":"1994","unstructured":"Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ (1994) Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and resistant skin bacteria from acne patients. Br J Dermatol 131:331\u2013336","journal-title":"Br J Dermatol"},{"key":"1568_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000067822","volume":"206","author":"EA Eady","year":"2003","unstructured":"Eady EA, Gloor M, Leyden JJ (2003) Propionibacterium acnes resistance: a worldwide problem. Dermatol 206:54\u201356","journal-title":"Dermatol"},{"key":"1568_CR15","first-page":"624","volume":"15","author":"M Ede","year":"1973","unstructured":"Ede M (1973) A double-blind, comparative study of benzoyl peroxide, benzoyl peroxide\u2013chlorhydroxyquinoline, benzoyl peroxide\u2013chlorhydroxyquinoline\u2013hydrocortisone, and placebo lotions in acne. Curr Ther Res Clin Exp 15:624\u2013629","journal-title":"Curr Ther Res Clin Exp"},{"key":"1568_CR16","first-page":"1382","volume":"10","author":"LF Eichenfield","year":"2011","unstructured":"Eichenfield LF, Alio Saenz AB (2011) Safety and efficacy of clindamycin phosphate 1.2\u00a0%-benzoyl peroxide 3\u00a0% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study. J Drugs Dermatol 10:1382\u20131396","journal-title":"J Drugs Dermatol"},{"key":"1568_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02652049609026042","volume":"13","author":"K Embil","year":"1996","unstructured":"Embil K, Nacht S (1996) The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul 13:575\u2013588","journal-title":"J Microencapsul"},{"key":"1568_CR18","unstructured":"Fakhouri T, Yentzer BA, Feldman SR (2009) Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol 657\u2013661"},{"key":"1568_CR19","first-page":"976","volume":"6","author":"SR Feldman","year":"2007","unstructured":"Feldman SR, Fleischer AB Jr (2007) A method to gain a sense of relative efficacy of acne medications that have not yet been studied. J Drugs Dermatol 6:976","journal-title":"J Drugs Dermatol"},{"key":"1568_CR20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jaad.2010.03.036","volume":"64","author":"SR Feldman","year":"2011","unstructured":"Feldman SR, Tan J, Poulin Y, Dirschka T, Kerrouche N, Manna V (2011) The efficacy of adapalene\u2013benzoyl peroxide combination increases with number of acne lesions. J Amer Acad Dermatol 64:1085\u20131091","journal-title":"J Amer Acad Dermatol"},{"key":"1568_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000018129","volume":"198","author":"JW Fluhr","year":"1999","unstructured":"Fluhr JW, Barsom O, Gehring W, Gloor M (1999) Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne. Dermatol 198:273\u2013277","journal-title":"Dermatol"},{"key":"1568_CR22","first-page":"4","volume":"83","author":"F Ghali","year":"2009","unstructured":"Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM (2009) Changing the face of acne therapy. Cutis 83:4\u201315","journal-title":"Cutis"},{"key":"1568_CR23","first-page":"110","volume":"84","author":"LS Gold","year":"2009","unstructured":"Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, Gidner J, Liu Y, Graeber M (2009) A North American study of adapalene\u2013benzoyl peroxide combination gel in the treatment of acne. Cutis 84:110\u2013116","journal-title":"Cutis"},{"key":"1568_CR24","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2133.2009.09209.x","volume":"161","author":"HP Gollnick","year":"2009","unstructured":"Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, Gore B, Liu Y, Graeber M (2009) Adapalene\u2013benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 161:1180\u20131189","journal-title":"Br J Dermatol"},{"key":"1568_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2230.1992.tb00196.x","volume":"17","author":"BR Hughes","year":"1992","unstructured":"Hughes BR, Norris JF, Cunliffe WJ (1992) A double-blind evaluation of topical isotretinoin 0.05\u00a0%, benzoyl peroxide gel 5\u00a0% and placebo in patients with acne. Clin Exp Dermatol 17:165\u2013168","journal-title":"Clin Exp Dermatol"},{"key":"1568_CR26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/clpt.2011.230","volume":"90","author":"S Ito","year":"2011","unstructured":"Ito S (2011) Placebo in clinical trials. Clin Pharmacol Ther 90:637\u2013639","journal-title":"Clin Pharmacol Ther"},{"key":"1568_CR27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.39524.439618.25","volume":"336","author":"TJ Kaptchuk","year":"2008","unstructured":"Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN, Nam BH, Nguyen LT, Park M, Rivers AL, McManus C, Kokkotou E, Drossman DA, Goldman P, Lembo AJ (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. Br Med J 336:999\u20131003","journal-title":"Br Med J"},{"key":"1568_CR28","first-page":"s53","volume":"9","author":"L Kircik","year":"2010","unstructured":"Kircik L, Friedman A (2010) Optimizing acne therapy with unique vehicles. J Drugs Dermatol 9:s53\u2013s57","journal-title":"J Drugs Dermatol"},{"key":"1568_CR29","first-page":"260","volume":"56","author":"AM Kligman","year":"1995","unstructured":"Kligman AM (1995) Acne vulgaris: tricks and treatments. Part II: the benzoyl peroxide saga. Cutis 56:260\u2013261","journal-title":"Cutis"},{"key":"1568_CR30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pain.2006.08.025","volume":"128","author":"R Klinger","year":"2007","unstructured":"Klinger R, Soost S, Flor H, Worm M (2007) Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin. Pain 128:31\u201339","journal-title":"Pain"},{"key":"1568_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00128071-200102010-00006","volume":"2","author":"JJ Leyden","year":"2001","unstructured":"Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF (2001) Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol 2:33\u201339","journal-title":"Am J Clin Dermatol"},{"key":"1568_CR32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pain.2006.12.006","volume":"128","author":"K Linde","year":"2007","unstructured":"Linde K, Witt CM, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B, Willich SN, Melchart D (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128:264\u2013271","journal-title":"Pain"},{"key":"1568_CR33","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","volume":"37","author":"DP Lookingbill","year":"1997","unstructured":"Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC (1997) Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 37:590\u2013595","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0190-9622(96)90497-1","volume":"35","author":"LC Lucchina","year":"1996","unstructured":"Lucchina LC, Kollias N, Gillies R, Phillips SB, Muccini JA, Stiller MJ, Trancik RJ, Drake LA (1996) Fluorescence photography in the evaluation of acne. J Am Acad Dermatol 35:58\u201363","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2133.1999.02768.x","volume":"140","author":"E Mallon","year":"1999","unstructured":"Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY (1999) The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140:672\u2013676","journal-title":"Br J Dermatol"},{"key":"1568_CR36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-4362.1986.tb04534.x","volume":"25","author":"OH Mills Jr","year":"1986","unstructured":"Mills OH Jr, Kligman AM, Pochi P, Comite H (1986) Comparing 2.5\u00a0%, 5\u00a0%, and 10\u00a0% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol 25:664\u2013667","journal-title":"Int J Dermatol"},{"key":"1568_CR37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D39SH763NC","volume":"16","author":"M Nino","year":"2010","unstructured":"Nino M, Calabro G, Santoianni P (2010) Topical delivery of active principles: the field of dermatological research. Dermatol Online J 16:4","journal-title":"Dermatol Online J"},{"issue":"9","key":"1568_CR38","first-page":"46","volume":"2","author":"No authors listed","year":"2009","unstructured":"No authors listed (2009) Benzoyl peroxide microsphere formulations: what is the science supporting microsphere vehicle technology and clinical use? J Clin Aesthet Dermatol. 2(9):46\u201354","journal-title":"J Clin Aesthet Dermatol."},{"key":"1568_CR39","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(04)17591-0","volume":"364","author":"M Ozolins","year":"2004","unstructured":"Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O\u2019Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC (2004) Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 364:2188\u20132195","journal-title":"Lancet"},{"key":"1568_CR40","first-page":"4","volume":"14","author":"H Pawin","year":"2004","unstructured":"Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dreno B (2004) Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 14:4\u201312","journal-title":"Eur J Dermatol"},{"key":"1568_CR41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0190-9622(08)80076-X","volume":"24","author":"PE Pochi","year":"1991","unstructured":"Pochi PE, Shalita AR, Strauss JS, Webster SB, Cunliffe WJ, Katz HI, Kligman AM, Leyden JJ, Lookingbill DP, Plewig G (1991) Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol 24:495\u2013500","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00403-013-1394-x","volume":"306","author":"G Sanclemente","year":"2014","unstructured":"Sanclemente G, Acosta JL, Tamayo ME, Bonfill X, Alonso-Coello P (2014) Clinical practice guidelines for treatment of acne vulgaris: a critical appraisal using the AGREE II instrument. Arch Dermatol Res 306:269\u2013277","journal-title":"Arch Dermatol Res"},{"key":"1568_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1037\/0033-2909.130.2.324","volume":"130","author":"S Stewart-Williams","year":"2004","unstructured":"Stewart-Williams S, Podd J (2004) The placebo effect: dissolving the expectancy versus conditioning debate. Psycholog Bull 130:324\u2013340","journal-title":"Psycholog Bull"},{"key":"1568_CR44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2753.2004.00512.x","volume":"11","author":"DA Stone","year":"2005","unstructured":"Stone DA, Kerr CE, Jacobson E, Conboy LA, Kaptchuk TJ (2005) Patient expectations in placebo-controlled randomized clinical trials. J Eval Clin Prac 11:77\u201384","journal-title":"J Eval Clin Prac"},{"key":"1568_CR45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","volume":"57","author":"DM Thiboutot","year":"2007","unstructured":"Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, Liu Y, Graeber M, Kang S (2007) Adapalene\u2013benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 57:791\u2013799","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","volume":"59","author":"D Thiboutot","year":"2008","unstructured":"Thiboutot D, Zaenglein A, Weiss J, Webster G, Calvarese B, Chen D (2008) An aqueous gel fixed combination of clindamycin phosphate 1.2\u00a0% and benzoyl peroxide 2.5\u00a0% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol 59:792\u2013800","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR47","first-page":"165","volume":"67","author":"EH Tschen","year":"2001","unstructured":"Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA, Levy SF (2001) A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis 67:165\u2013169","journal-title":"Cutis"},{"key":"1568_CR48","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0190-9622(91)70109-F","volume":"24","author":"RC Wester","year":"1991","unstructured":"Wester RC, Patel R, Nacht S, Leyden J, Melendres J, Maibach H (1991) Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J Am Acad Dermatol 24:720\u2013726","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR49","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0190-9622(98)70442-6","volume":"39","author":"GM White","year":"1998","unstructured":"White GM (1998) Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol 39:S34\u2013S37","journal-title":"J Am Acad Dermatol"},{"key":"1568_CR50","author":"S Younis","year":"2014","unstructured":"Younis S, Javed Q (2014) The interleukin-6 and interleukin-1A gene promoter polymorphism is associated with the pathogenesis of acne vulgaris. Arch Dermatol Res. doi: 10.1007\/s00403-014-1519-x:","journal-title":"Arch Dermatol Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-015-1568-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1568-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T13:21:48Z","timestamp":1652275308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-015-1568-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s00403-015-1568-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]}}}